Advertisement

Clinical Rheumatology

, Volume 37, Issue 4, pp 1027–1035 | Cite as

Clinical characteristics of autoimmune rheumatic disease-related organizing pneumonia

  • Xin Dong
  • Yi Zheng
  • Li Wang
  • Wen-hui Chen
  • Yun-gang Zhang
  • Qiang Fu
Original Article

Abstract

To study the clinical characteristics of autoimmune rheumatic disease-related organizing pneumonia (AIRD-OP), the clinical presentation, radiological findings, treatment, and outcome of AIRD-OP patients were analyzed, in comparison with patients with cryptogenic organizing pneumonia (COP). A total of 131 OP patients were identified, including 57 cases of AIRD-OP, 35 cases of COP, and 39 cases of other disease-related OPs. Among AIRD-OP patients, 36 (63%) presented the symptoms of OP at onset. The primary disease of AIRDs included Sjogren’s syndrome (38%), polymyositis/dermatomyositis (23%), rheumatoid arthritis (23%), and undifferentiated AIRD. Compared with COP patients, the prevalence of patients having cough and malaise at baseline was significantly lower (54.4 vs 82.9%, P < 0.05; 49.1 vs 70.6%, P < 0.05), and the signs of moist rales and crackles were more common in AIRD-OP patients (54.4 vs 32.4%, P < 0.05; 49.1 vs 26.5%, P < 0.05). Lung function (TLC%, FVC%) was more significantly reduced in AIRD-OP patients (72 vs 97%, P < 0.05;75 vs 96%, P < 0.05). The dosage of corticosteroids prescribed was significantly higher in AIRD-OP patients (44 vs 37 mg/day, P < 0.05). The complete recovery rate was slightly lower in AIRD-OP patients (22.2 vs 29%, P > 0.05) with a tendency towards higher recurrence rate in AIRD-OP patients (32.7 vs 14.3%, P < 0.05). AIRD-OP may be the most common cause of OP. OP can be the initial presentation of AIRD. Compared with COP patients, AIRD-OP patients are characterized with occult onset but more severe lung involvement and higher recurrence rate.

Keywords

Autoimmune rheumatic diseases Organizing pneumonia 

Notes

Acknowledgements

Xin Dong not only collected the data and wrote the manuscript but also prepared the figures. Besides, Yi Zheng supervised the study.

Compliance with ethical standards

Disclosures

None.

References

  1. 1.
    Gutsche M, Rosen GD, Swigris JJ (2012) Connective tissue disease-associated interstitial lung disease: a review. Curr Respir Care Rep 1:224–232CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Lamblin C, Bergoin C, Saelens T, Wallaert B (2001) Interstitial lung diseases in collagen vascular diseases. Eur Respir J Suppl 32:69s–80sPubMedGoogle Scholar
  3. 3.
    Cordier JF (2006) Cryptogenic organising pneumonia. Eur Respir J 28:422–446CrossRefPubMedGoogle Scholar
  4. 4.
    Yoo JW, Song JW, Jang SJ, Lee CK, Kim MY, Lee HK, Jegal Y, Kim DS (2011) Comparison between cryptogenic organizing pneumonia and connective tissue disease-related organizing pneumonia. Rheumatology (Oxford) 50:932–938CrossRefGoogle Scholar
  5. 5.
    Kaushik P, Cooper ES, Banda VR, Vatsavai SR, Kaushik R (2005) Bronchiolitis obliterans with organizing pneumonia in rheumatoid arthritis—a fatal case and short review of literature. Rheumatol Int 25:391–393CrossRefPubMedGoogle Scholar
  6. 6.
    Cohen AJ, King TE Jr, Downey GP (1994) Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med 149:1670–1675CrossRefPubMedGoogle Scholar
  7. 7.
    Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, Jones KD, King TE Jr (2007) Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176:691–697CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Arnett FC, Edworthy SM, Bloch DA, DJ MS, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315–324CrossRefPubMedGoogle Scholar
  10. 10.
    Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347CrossRefPubMedGoogle Scholar
  11. 11.
    Mosca M, Tani C, Vagnani S et al (2014) The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun 48–49:50–52CrossRefPubMedGoogle Scholar
  12. 12.
    Travis WD, Costabel U, Hansell DM et al (2013) An official American Thoracic Society/ European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733–748CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    American Thoracic Society, European Respiratory Society (2002) American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:277–304CrossRefGoogle Scholar
  14. 14.
    Gutsche M, Rosen GD, Swigris JJ (2012) Connective tissue disease-associated interstitial lung disease: a review. Curr Respir Care Rep 21:224–232CrossRefGoogle Scholar
  15. 15.
    Drakopanagiotakis F, Polychronopoulos V, Judson MA (2008) Organizing pneumonia. Am J Med Sci 335:34–39CrossRefPubMedGoogle Scholar
  16. 16.
    Schlesinger C, Koss MN (2005) The organizing pneumonias: an update and review. Curr Opin Pulm Med 11:422–430CrossRefPubMedGoogle Scholar
  17. 17.
    Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M, Aswad B, Karagianidis N, Kastanakis E, Braman SS, Polychronopoulos V (2011) Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis. Chest 139:893–900CrossRefPubMedGoogle Scholar
  18. 18.
    Sveinsson OA, Isaksson HJ, Sigvaldason A, Yngvason F, Aspelund T, Gudmundsson G (2007) Clinical features in secondary and cryptogenic organising pneumonia. Int J Tuberc Lung Dis 11:689–694PubMedGoogle Scholar
  19. 19.
    Schlesinger C, Koss MN (2006) The organizing pneumonias: a critical review of current concepts and treatment. Treat Respir Med 5:193–206CrossRefPubMedGoogle Scholar
  20. 20.
    Aguiar M, Felizardo M, Mendes AC, Moniz D, Sotto-Mayor R (2010) Bugalho de Almeida A. Organising pneumonia—the experience of an outpatient clinic of a central hospital. Rev Port Pneumol 16:369–389CrossRefPubMedGoogle Scholar
  21. 21.
    Oiwa H, Maeda A, Nishisaka T, Yamanishi Y, Yamana S, Takanashi A (2004) A case of polymyositis complicated with organizing pneumonia: case report and literature review. Mod Rheumatol 14:388–393CrossRefPubMedGoogle Scholar
  22. 22.
    Matteson EL, Ike RW (1990) Bronchiolitis obliterans organizing pneumonia and Sjogren’s syndrome. J Rheumatol 17:676–679PubMedGoogle Scholar
  23. 23.
    Lambert M, Hebbar M, Viget N, Hatron PY, Hachulla E, Devulder B (2000) Bronchiolitis obliterans with organized pneumonia: a rare complication of primary Gougerot-Sjogren syndrome. Rev Med Interne 21:74–77CrossRefPubMedGoogle Scholar
  24. 24.
    Ioannou S, Toya SP, Tomos P, Tzelepis GE (2008) Cryptogenic organizing pneumonia associated with primary Sjogren’s syndrome. Rheumatol Int 28:1053–1055CrossRefPubMedGoogle Scholar
  25. 25.
    Shi JH, Liu HR, Xu WB, Feng RE, Zhang ZH, Tian XL, Zhu YJ (2009) Pulmonary manifestations of Sjogren’s syndrome. Respiration 78:377–386CrossRefPubMedGoogle Scholar
  26. 26.
    Tzelepis GE, Toya SP, Moutsopoulos HM (2008) Occult connective tissue diseases mimicking idiopathic interstitial pneumonias. Eur Respir J 31:11–20CrossRefPubMedGoogle Scholar
  27. 27.
    Mori S, Cho I, Koga Y, Sugimoto M (2008) A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature. Mod Rheumatol 18:60–66CrossRefPubMedGoogle Scholar
  28. 28.
    Kinoshita Y, Sakamoto A, Hidaka K (2014) Organizing pneumonia preceding rheumatoid arthritis. Case Rep Pulmonol 2014:758619PubMedPubMedCentralGoogle Scholar
  29. 29.
    Henriet AC, Diot E, Marchand-Adam S, de Muret A, Favelle O, Crestani B, Diot P (2010) Organising pneumonia can be the inaugural manifestation in connective tissue diseases, including Sjogren’s syndrome. Eur Respir Rev 19:161–163CrossRefPubMedGoogle Scholar
  30. 30.
    Komiya K, Teramoto S, Kurosaki Y, Kashizaki F, Kawashima M, Masuda K, Akagawa S, Hebisawa A, Ishii H, Kadota J (2010) Organizing pneumonia with a positive result for anti-CCP antibodies as the first clinical presentation of rheumatoid arthritis. Intern Med 49:1605–1607CrossRefPubMedGoogle Scholar
  31. 31.
    Nadashkevich O, Davis P, Fritzler M et al (2006) A randomized unblended trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis. Clin Rearheumatol 25:205–212CrossRefGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2017

Authors and Affiliations

  1. 1.Department of Rheumatology, Beijing Chao-yang HospitalCapital Medical UniversityBeijingChina
  2. 2.Department of RadiologyBeijing Chao-yang HospitalBeijingChina
  3. 3.Department of RespirationBeijing Chao-yang HospitalBeijingChina
  4. 4.Department of PathologyBeijing Chao-yang HospitalBeijingChina

Personalised recommendations